[go: up one dir, main page]

BR9501654A - Utilização de ao menos um agente antifúngico e de ao menos um agente antibacteriano halogenado e processo de tratamento cosmético dos cabelos e/ou do couro cabeludo - Google Patents

Utilização de ao menos um agente antifúngico e de ao menos um agente antibacteriano halogenado e processo de tratamento cosmético dos cabelos e/ou do couro cabeludo

Info

Publication number
BR9501654A
BR9501654A BR9501654A BR9501654A BR9501654A BR 9501654 A BR9501654 A BR 9501654A BR 9501654 A BR9501654 A BR 9501654A BR 9501654 A BR9501654 A BR 9501654A BR 9501654 A BR9501654 A BR 9501654A
Authority
BR
Brazil
Prior art keywords
treatment process
agent
cosmetic hair
scalp treatment
antibacterial agent
Prior art date
Application number
BR9501654A
Other languages
English (en)
Inventor
Didier Saint-Leger
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of BR9501654A publication Critical patent/BR9501654A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/05—Stick

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9501654A 1994-05-05 1995-05-04 Utilização de ao menos um agente antifúngico e de ao menos um agente antibacteriano halogenado e processo de tratamento cosmético dos cabelos e/ou do couro cabeludo BR9501654A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9405541A FR2719481B1 (fr) 1994-05-05 1994-05-05 Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.

Publications (1)

Publication Number Publication Date
BR9501654A true BR9501654A (pt) 1996-03-05

Family

ID=9462924

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9501654A BR9501654A (pt) 1994-05-05 1995-05-04 Utilização de ao menos um agente antifúngico e de ao menos um agente antibacteriano halogenado e processo de tratamento cosmético dos cabelos e/ou do couro cabeludo

Country Status (11)

Country Link
US (3) US5650145A (pt)
EP (1) EP0680745B1 (pt)
JP (1) JP2780951B2 (pt)
KR (1) KR0163241B1 (pt)
CN (1) CN1079660C (pt)
BR (1) BR9501654A (pt)
CA (1) CA2148651C (pt)
DE (1) DE69528721T2 (pt)
ES (1) ES2186707T3 (pt)
FR (1) FR2719481B1 (pt)
MX (1) MX9502035A (pt)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855872A (en) * 1992-06-22 1999-01-05 Libin; Barry M. Compositions for treating herpes simplex virus infections
FR2719481B1 (fr) * 1994-05-05 1996-05-31 Oreal Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.
DE19643831A1 (de) 1996-10-30 1998-05-07 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von schwer therapierbaren Schleimhauterkrankungen
DK0884997T3 (da) * 1996-02-16 2002-09-16 Janssen Pharmaceutica Nv Sammensætninger, der indeholder en afsvampnings- og en svovlforbindelse
DE19639817A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von Hautinfektionen
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US6099870A (en) * 1997-12-18 2000-08-08 Johnson & Johnson Consumer Companies, Inc. Methods for improving the health of hair and scalp
US6207694B1 (en) 1998-07-27 2001-03-27 Howard Murad Pharmaceutical compositions and methods for managing scalp conditions
US20070015698A1 (en) * 1998-07-30 2007-01-18 United States Of America As Represented By The Secretary Of Health Treatment of skin, and wound repair, with thymosin beta 4
DE69924615T3 (de) * 1998-07-30 2011-05-05 The Government Of The United States Of America, Represented By The Department Of Health & Human Services, National Institute Of Health, Office Of Technology Transfer Thymosin beta 4 stimuliert wundheilung
FR2793680B1 (fr) * 1999-04-26 2002-08-02 Oreal Utilisation de composes antifongiques halogenes et de composes antibacteriens cationiques pour traiter les rougeurs cutanees et/ou les desordres desquamatifs lies a malassezia spp
US6436926B1 (en) 1999-05-10 2002-08-20 Medpointe, Inc. Compositions and methods for treating superficial fungal infections
CA2371728C (en) * 1999-06-11 2009-06-02 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US6861397B2 (en) * 1999-06-23 2005-03-01 The Dial Corporation Compositions having enhanced deposition of a topically active compound on a surface
US6107261A (en) 1999-06-23 2000-08-22 The Dial Corporation Compositions containing a high percent saturation concentration of antibacterial agent
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
DE10022418A1 (de) * 2000-05-09 2001-11-15 Henkel Kgaa Verfahren zur Schuppenbekämpung
JP2004536034A (ja) 2001-01-08 2004-12-02 ネオルクス コーポレイション 治療的および診断的化合物、組成物および方法
DE10111288A1 (de) * 2001-03-09 2002-09-12 Wella Ag Antischuppenmittel
PL210859B1 (pl) 2001-03-23 2012-03-30 Genencor Int Odmiana subtylizyny zawierająca zmieniony epitop limfocytów T, kwas nukleinowy kodujący tę odmianę subtylizyny, wektor ekspresyjny i komórka gospodarza zawierająca kwas nukleinowy oraz kompozycje zawierające tę odmianę subtylizyny
WO2003028762A1 (en) * 2001-09-28 2003-04-10 Ethicon, Inc. Novel antimicrobial resistance blocking compositions
KR20030044553A (ko) * 2001-11-30 2003-06-09 주식회사 엘지생활건강 살균 및 소취기능을 갖는 습윤 와이프
WO2003051403A1 (en) 2001-12-13 2003-06-26 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
WO2003057713A2 (en) 2001-12-31 2003-07-17 Genencor International, Inc. Proteases producing an altered immunogenic response and methods of making and using the same
GB0205531D0 (en) * 2002-03-08 2002-04-24 Unilever Plc Hair treatment compositions
WO2003082232A1 (en) 2002-03-28 2003-10-09 The Procter & Gamble Company Particle stabilizing compositions
JPWO2004028502A1 (ja) * 2002-09-27 2006-01-19 持田製薬株式会社 抗真菌剤および抗細菌剤配合洗浄用組成物
EP2500423B1 (en) 2003-02-26 2015-06-17 Danisco US Inc. Amylases producing an altered immunogenic response and methods of making and using the same
CA2424003A1 (en) * 2003-03-28 2004-09-28 Austin & Repatriation Medical Centre Anti-microbial topical composition comprising alcohol and chlorhexidine salt
WO2004089406A1 (es) * 2003-04-09 2004-10-21 Harold Armando Gomez Torres Composición tópica en forma de gel para el tratamiento de quemaduras de la piel
US7326717B2 (en) 2003-05-06 2008-02-05 L'oreal Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
WO2005032529A1 (ja) * 2003-09-30 2005-04-14 Kobayashi Pharmaceutical Co., Ltd. 抗真菌組成物
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
JP2006151938A (ja) * 2004-10-26 2006-06-15 Hamamatsu Univ School Of Medicine 育毛剤
DE102005005009A1 (de) * 2005-02-03 2005-11-03 Clariant Gmbh Konservierungsmittel
DE502006000770D1 (de) * 2005-02-03 2008-06-26 Clariant Produkte Deutschland Konservierungsmittel
US20060193804A1 (en) * 2005-02-24 2006-08-31 L'oreal Haircare use of cyclic amine derivatives
WO2006098154A1 (ja) * 2005-03-14 2006-09-21 National University Corporation, Hamamatsu University School Of Medicine 育毛剤
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7927614B2 (en) 2006-02-03 2011-04-19 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
EP1897533A1 (en) * 2006-09-08 2008-03-12 Revotar Biopharmaceuticals AG Use of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha -D-mannopyranosyl-oxy)-phenyl] hexane for the preparation of cosmetic compositions
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
EP1946756A1 (en) * 2007-01-17 2008-07-23 Revotar Biopharmaceuticals AG Use of entacapone in cosmetic, dermatological and pharmaceutical compositions
FR2915097B1 (fr) 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques.
FR2920309B1 (fr) 2007-08-28 2010-05-28 Galderma Res & Dev Utilisation de travoprost pour traiter la chute des cheveux
US20090117213A1 (en) * 2007-11-06 2009-05-07 Clermont Beaulieu Stable solutions having antiviral, antibacterial and hemostatic properties and methods of making thereof
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
FR2929118B1 (fr) 2008-03-28 2010-05-07 Oreal Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
FR2929117B1 (fr) 2008-03-28 2010-05-07 Oreal Utilisation de l'association du 2,4-diaminopyrimidine 3-n-oxyde et du madecassosside et/ou du terminoloside pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
JP6203820B2 (ja) 2012-04-16 2017-09-27 ケース ウエスタン リザーブ ユニバーシティ １５−ｐｇｄｈ活性を調節する組成物および方法
EP3057973B1 (en) 2013-10-15 2019-09-04 Case Western Reserve University Compositions comprising a 15-pgdh inhibitor for the healing of wounds
WO2016090373A1 (en) 2014-12-05 2016-06-09 Case Western Reserve University Compositions and methods of modulating s-nitrosylation
DE102015225554A1 (de) * 2015-12-17 2017-06-22 Henkel Ag & Co. Kgaa "Mittel zur temporären Verformung keratinhaltiger Fasern mit Konservierungsmittel III"
DE102015225558A1 (de) * 2015-12-17 2017-06-22 Henkel Ag & Co. Kgaa Mittel zur temporären Verformung keratinhaltiger Fasern mit Konservierungsmittel II
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
AU2018215678A1 (en) 2017-02-06 2019-08-22 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
MA55147A (fr) 2018-11-21 2021-09-29 Univ Texas Compositions et procédés de modulation de l'activité de la déshydrogénase à chaîne courte
MX2022014637A (es) 2020-05-20 2023-03-03 Rodeo Therapeutics Corp Composiciones y metodos para modular la actividad de deshidrogenasas de cadena corta.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
LU86944A1 (fr) * 1987-07-17 1989-03-08 Oreal Composition a base de derives d'hydroxypyridone pour diminuer la chute des cheveux
JP2811481B2 (ja) * 1989-11-20 1998-10-15 株式会社コーセー 養毛料
JP2931708B2 (ja) * 1991-07-18 1999-08-09 ポーラ化成工業株式会社 養毛料
WO1993007847A1 (en) * 1991-10-15 1993-04-29 Kenneth Vincent Mason Anti-seborrhoeic formulation
FR2685867B1 (fr) * 1992-01-07 1995-06-09 Thorel Jean Compositions contre la desquamation de l'epiderme et du cuir chevelu.
FR2694694B1 (fr) * 1992-08-13 1994-10-28 Thorel Jean Noel Composition active pour le traitement du psoriasis, notamment le psoriasis du cuir chevelu.
FR2719481B1 (fr) * 1994-05-05 1996-05-31 Oreal Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.

Also Published As

Publication number Publication date
KR0163241B1 (ko) 1998-12-01
EP0680745A3 (fr) 1997-03-26
ES2186707T3 (es) 2003-05-16
US5919438A (en) 1999-07-06
CN1112825A (zh) 1995-12-06
KR950031023A (ko) 1995-12-18
FR2719481B1 (fr) 1996-05-31
DE69528721D1 (de) 2002-12-12
MX9502035A (es) 1997-02-28
JP2780951B2 (ja) 1998-07-30
US6121254A (en) 2000-09-19
JPH0853329A (ja) 1996-02-27
DE69528721T2 (de) 2003-03-20
FR2719481A1 (fr) 1995-11-10
EP0680745A2 (fr) 1995-11-08
EP0680745B1 (fr) 2002-11-06
US5650145A (en) 1997-07-22
CN1079660C (zh) 2002-02-27
CA2148651A1 (fr) 1995-11-06
CA2148651C (fr) 2000-07-18

Similar Documents

Publication Publication Date Title
BR9501654A (pt) Utilização de ao menos um agente antifúngico e de ao menos um agente antibacteriano halogenado e processo de tratamento cosmético dos cabelos e/ou do couro cabeludo
BR9504902A (pt) Compostos utilização de compostos composição cosmética e processo de proteção da pele e/ou dos cabelos contra a radiação ultravioleta
BR9609532A (pt) Composição antimicrobiana para o tratamento de cabelo processo para o tratamento de caspa e uso da composição
BR9504923A (pt) Compostos utilização de compostos composição cosmética e processo de proteção da pele e/ou dos cabelos contra a radiação ultravioleta
BR9600510A (pt) Composição cosmética dispositivo de acondicionamento processo de tratamento de materiais queratinicos e processo de alisamento ou de desencrespamento dos cabelos
BR9303433A (pt) Composicao viscoelastica linear para a higiene ou cuidados pessoais,processo para a promocao da higiene e cuidados pessoais,processo para a fixacao dos cabelos,processo para a promocao da higiene e cuidados da pele,e,uso de um agente espessante polimerico
BR9610522A (pt) Composição para lavagem do corpo e processo para o tratamento da pele
BR9601404A (pt) Composição de limpeza e condicionamento combinados e processo de limpeza e condicionamento concomitantes da pele ou dos cabelos
BR9702054A (pt) Composição cosmética processo de tratamento cosmético das matérias queratínicas e utilização da composição
PL291446A1 (en) Agent for treating fibre as well as for hair and skin care
BR9702541A (pt) Composição cosmética e/ou dermatológica utilização da composição e processo para tratamento não-terapêutico cosmético
BR9708056A (pt) Composição para cuidados dos cabelos e processo para condicionar e proporcionar estilo ao cabelo
BR9603072A (pt) Agente de tratamento do cabelo e processo para a sua preparação
BR9707623A (pt) Composição cosmética processo de tratamento cosmético das matérias queratínicas e utilização da composição
BR9701309A (pt) Agente e processo para o tingimento oxidativo de fibras de queratina
DE69302257D1 (de) Pilzhemmendes und hautheilungsförderndes Mittel
BR9610375A (pt) Extrato de células composição cosmética ou farmacêutica utilização de pelo menos um extrato de células e processo de tratamento cosmético
BR9501289A (pt) Composição de xampu processo de condicionador cabelos e/ou pele e uso como aditivo
BR9604009A (pt) Composição estável para aplicação tópica contendo pelo menos um agente ativo com uma ação tópica sensível à pele e pelo menos um poliol composição de limpeza para a pele e/ou fibras queratínicas contendo pelo menos uma enzima e pelo menos um poliol utilização da composição utilização processo cosmético para limpar e/ou proteger a pele e/ou as fibras queratínicas
BR9708362A (pt) Utilização de uma quantidade eficaz de um extrato e processo de tratamento cosmético
BR9801339A (pt) Composição tópica sólida aquosa e processo de tratamento cosmético da pele das mucosas dos cabelos ou dos fâneros
BR9504901A (pt) Compostos utilização de compostos composição cosmética e processo de proteção da pele e/ou dos cabelos contra a radiação ultravioleta
BR9606470A (pt) Composição cosmética de uso tópico utilização da composição e processo de tratamento cosmético para proteger a pele e/ou os cabelos contra a radiação ultravioleta
BR9504906A (pt) Compostos utilização de compostos composição cosmética e processo de proteção da pele e/ou dos cabelos contra a radiação ultravioleta
BR9609602A (pt) Composição cosmética anidra utilização da composição e processo de tratamento cosmético

Legal Events

Date Code Title Description
EE Request for examination
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FF Decision: intention to grant
FG9A Patent or certificate of addition granted
B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 14A,15A E 16A ANUIDADES

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AO NAO CUMPRIMENTO DO DESPACHO 24.3 NA RPI 2100 DE 05/04/2011 E COMPROVAR RECOLHIMENTO DA 17A E 18A ANUIDADES.

B15K Others concerning applications: alteration of classification

Ipc: A61K 8/36 (2006.01), A61K 8/23 (2006.0